Subclinical coronary atherosclerosis, HIV infection and antiretroviral therapy: Multicenter AIDS Cohort Study

AIDS

Volumn 22, Issue 13, 2008, Pages 1589-1599

  Kingsley, Lawrence A ^a,b   Cuervo Rojas, Juliana ^c   Muñoz, Alvaro ^c   Palella, Frank J ^d   Post, Wendy ^e   Witt, Mallory D ^f   Budoff, Matthew ^g   Kuller, Lewis ^b  

^a Department of Infectious Diseases and Microbiology ^*  (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e University School of Medicine   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; LIPID;

ADULT; AGE; AGED; ARTERY CALCIFICATION; ARTICLE; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DRUG UTILIZATION; DYSLIPIDEMIA; ELECTRON BEAM TOMOGRAPHY; FAMILY HISTORY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIDETECTOR COMPUTED TOMOGRAPHY; PREVALENCE; PRIORITY JOURNAL; RACE; SMOKING; STATISTICAL ANALYSIS; ANGIOCARDIOGRAPHY; BLOOD; CALCINOSIS; CASE CONTROL STUDY; CHRONIC DISEASE; CLINICAL TRIAL; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY DISEASE; MIDDLE AGED; RADIOGRAPHY; STATISTICAL MODEL;

ADULT; AGED; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CALCINOSIS; CASE-CONTROL STUDIES; CHRONIC DISEASE; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; HIV INFECTIONS; HUMANS; LIPIDS; LOGISTIC MODELS; MALE; MIDDLE AGED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 52249123479     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e328306a6c5     Document Type: Article

References (42)

1. Riddler SA, Smit E, Cole SR, Li R, Chmiel JS, Dobs A, et al. Impact of HIV infection and HAART on serum lipids in men. JAMA 2003; 289:2978-2982.
2. Brown TT, Cole SR, Li X, Kingsley LA, Palella FJ, Riddler SA, et al. Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. Arch Intern Med 2005; 165:1179-1184.
3. Brown T, Li X, Cole S, Kingsley L, Palella F, Riddler S, et al. Cumulative exposure to nucleoside analogue reverse transcrip-tase inhibitors is associated with insulin resistance markers in the multicenter AIDS cohort study. AIDS 2005; 19:1375-1383.
4. Seaberg E, Muñoz A, Lu M, Detels R, Margolick J, RiddlerS, et al. Association between highly active antiretroviral therapy and hypertension in a large cohort of men followed from 1984 to 2003. AIDS 2005; 19:953-960.
5. Grinspoon S, Carr A. Cardiovascular risk and body-fat abnormalities in HIV-infected adults. N Engl J Med 2005; 352:48-62.
6. Bozzette SA, Ake CF, Tam HK, Chang SW, Louis TA. Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection. N Engl J Med 2003; 348:702-710.
7. Escaut L, Monsuez JJ, Chironi G, Merad M, Teicher E, Smadja D, et al. Coronary artery disease in HIV infected patients. Intensive Care Med 2003; 29:969-973.
8. Klein D, Hurley L, Quesenberry C Jr, Sidney S. Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection? J Acquir Immune Defic Syndr 2002; 30:471-477.
9. Coplan PM, Nikas A, Japour A, Cormier K, Maradit-Kremers H, Lewis R, et al. Incidence of myocardial infarction in randomized clinical trials of protease inhibitor-based antiretroviral therapy: an analysis of four different protease inhibitors. AIDS Res Hum Retroviruses 2003; 19:449-455.
10. Currier JS, Taylor A, Boyd F, Dezii CM, Kawabata H, Burtcel B, et al. Coronary heart disease in HIV-infected individuals. J Acquir Immune Defic Syndr 2003; 33:506-512.
11. The DAD Study Group. Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med 2007; 356:1723-1735.
12. d'Arminio A, Sabin C, Phillips A, Reiss P, Weber R, KirkO, et al. Cardio- and cerebrovascular events in HIV-infected persons. AIDS 2004; 18:1811-1817.
13. MaryKrause M, Cotte L, Simon A, Partisani M, Costagliola D, and the Clinical Epidemiology Group from the French Hospital Database. Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men. AIDS 2003; 17:2479-2486.
14. Rickerts V, Brodt H, Staszewski S, Stille W. Incidence of myocardial infarctions in HIV-infected patients between 1983 and 1998: the Frankfurt HIV-cohort study. Eur J Med Res 2000; 5:329-333.
15. Holmberg SD, Moorman AC, Williamson JM, Tong TC, Ward DJ, Wood KC, et al. Protease inhibitors and cardiovascular outcomes in patients with HIV-1. Lancet 2002; 360:1747-1748.
16. Triant VA, Lee H, Hadigan C, Grinspoon SK. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab 2007; 92:2506-2512.
17. The Strategies for Management of Antiretroviral Therapy (SMART) Study Group. CD4R count-guided interruption of antiretroviral treatment. N Engl J Med 2006; 355:2283-2296.
18. Acevedo M, Sprecher DL, Calabrese L, Pearce GL, Coyner DL, Hal l iburton SS, et al. Pilot study of coronary atherosclerotic risk and plaque burden in HIV patients: 'a call for cardiovascular prevention'. Atherosclerosis 2002; 163:349-354.
19. Mangili A, Gerrior J, Tang A, O'Leary D, Polak J, Schaefer E, et al. Risk of cardiovascular disease in a cohort of HIV-infected adults: a study using carotid intima-media thickness and coronary artery calcium score. Clin Infect Dis 2006; 43:1482-1489.
20. Talwani R, Falusi OM, Mendes de Leon CF, Nerad JL, Rich S, Proia LA, et al. Electron beam computed tomography for assessment of coronary artery disease in HIV-infected men receiving antiretroviral therapy. J Acquir Immune Defic Syndr 2002; 30:191-195.
21. Lai S, Lai H, Celentano DD, Vlahov D, Ren S, Margolick J, et al. Factors associated with accelerated atherosclerosis in HIV-1-infected persons treated with protease inhibitors. AIDS Patient Care STDS 2003; 17:211-219.
22. Lai S, Lima JAC, Lai H, Vlahov D, Celentano D, Tong W, et al. Human immunodeficiency virus 1 infection, cocaine, and coronary calcification. Arch Intern Med 2005; 165:690-695.
23. Robinson FPACRN, Hoff JA, Kondos GT. Coronary artery calcium in HIV-infected men treated with highly active antiretroviral therapy. J Cardiovasc Nurs 2005; 20:149-154.
24. Greenland P, Bonow RO, Brundage BH, Budoff MJ, Eisenberg MJ, Grundy SM, et al. ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography) developed in collaboration with the Society of Atherosclerosis Imaging and Prevention and the Society of Cardiovascular Computed Tomography. J Am Coll Cardiol 2007; 49:378-402.
25. Stary HC. The development of calcium deposits in atherosclerotic lesions and their persistence after lipid regression. Am J Cardiol 2001; 88:16E-19E.
26. Rumberger JA, Schwartz RS, Simons DB, Sheedy PF, Edwards WD, Fitzpatrick LA. Relation of coronary calcium determined by electron beam computed tomography and lumen narrowing determined by autopsy. Am J Cardiol 1994; 73:1169-1173.
27. Sangiorgi G, RumbergerJA, Severson A, Edwards WD, GregoireJ, Fitzpatrick LA, et al. Arterial calcification and not lumen stenosis is highly correlated with atherosclerotic plaque burden in humans: a histologic study of 723 coronary artery segments using nondecalcifying methodology. J Am Coll Cardiol 1998; 31:126-133.
28. Detrano RC, Anderson M, Nelson J, Wong ND, Carr JJ, McNitt-Gray M, et al. Coronary calcium measurements: effect of CT scanner type and calcium measure on rescan reproducibility: MESA study. Radiology 2005; 236:477-484.
29. Greenland P, LaBree L, Azen SP, Doherty TM, Detrano RC. Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA 2004; 291:210-215.
30. Arad Y, Goodman KJ, Roth M, Newstein D, Guerci AD. Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events: the St. Francis Heart Study. J Am Coll Cardiol 2005; 46:158-165.
31. Agatston A, Janowitz W, Hildner F, Zusmer N, Viamonte M, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol1990; 15: 827-832.
32. DHHS/Henry J. Kaiser Family Foundation Panel on Clinical Practices for the Treatment of HIV infection. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents 2006 revision. 2006. pp. 1-112. http://aidsinfo.nih.gov/ ContentFiles/AdultandAdolescentGL05042006050. pdf.
33. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2005; 28(Suppl 1):S37-S42.
34. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285:2486-2497.
35. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289:2560-2571.
36. AllainCC, Poon LS, Chan CSG, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem 1974; 20:470-475.
37. Warnick GR, Albers JJ. A comprehensive evaluation of the heparin: manganese precipitation procedure for estimating high density lipoprotein cholesterol. J Lipid Res 1978; 19:65-76.
38. Rifai N, Iannotti E, DeAngelis K, Law T. Analytical and clinical performance of a homogeneous enzymatic LDL-cholesterol assay compared with the ultracentrifugation-dextran sulfate-Mg2R method. Clin Chem 1998; 44:1242-1250.
39. Bucolo G, David H. Quantitative determination of serum trigly-cerides by the use of enzymes. Clin Chem 1973; 19:476-482.
40. Giorgi JV, Cheng H, Margolick JB, Bauer KD, Ferbas J, Waxdal M, et al. Quality control in the flow cytometric measurement of T-lymphocyte subsets: the multicenter AIDS cohort study experience. The Multicenter AIDS Cohort Study Group. Clin Immunol Immunopathol 1990; 55:173-186.
41. McClelland RL, Chung H, Detrano R, Post W, Kronmal RA. Distribution of coronary artery calcium by race, gender, and age: results from the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 2006; 113:30-37.
42. van Leuven SI, Franssen R, Kastelein JJ, Levi M, Stroes ESG, Tak PP. Systemic inflammation as a risk factor for atherothrombosis. Rheumatology 2008; 47:3-7.